SO
NVCT icon

STRS Ohio’s Nuvectis Pharma NVCT Stock Holding History

STRS Ohio’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$500K Buy
+27,200
New +$305K ﹤0.01% 1150
2024
Q2 		– Sell
-5,800
Closed -$47K – 2055
2024
Q1 		$47K Sell
5,800
-400
-6% -$3.4K ﹤0.01% 1770
2023
Q4 		$51K Buy
6,200
+2,300
+59% +$20.5K ﹤0.01% 1772
2023
Q3 		$50K Buy
3,900
+2,500
+179% +$36.2K ﹤0.01% 1793
2023
Q2 		$22K Buy
+1,400
New +$22.3K ﹤0.01% 1880

Other funds holding NVCT

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

STRS Ohio's NVCT Position: Q2 2026 in Review

STRS Ohio opened a new position in Nuvectis Pharma (NVCT) in Q2 2026: 27,200 shares worth $500K. The stake represents ﹤0.01% of the portfolio and ranks #1150 among its holdings. This is a return to the name: STRS Ohio previously reported a position in NVCT as recently as Q1 2024.

STRS Ohio first reported a position in NVCT in Q2 2023 and has held it in 5 quarters since. 83 funds tracked by Wall St. Rank hold NVCT as of Q2 2026.

  • STRS Ohio held 27,200 shares of Nuvectis Pharma worth $500K as of Q2 2026.
  • Nuvectis Pharma was a new STRS Ohio position in Q2 2026.
  • Nuvectis Pharma made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1150 holding.
  • STRS Ohio first reported a position in Nuvectis Pharma in Q2 2023 and has held it in 5 quarters since.
  • 83 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.